When to start antiretroviral therapy in HIV-associated tuberculosis

New England Journal of Medicine

Volumn 365, Issue 16, 2011, Pages 1538-1540

  Török, M Estée ^a   Farrar, Jeremy J ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PLACEBO; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; THERAPY DELAY; TUBERCULOUS MENINGITIS;

EID: 80054717089     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1109546     Document Type: Editorial

References (11)

1. Dean GL, Edwards SG, Ives NJ, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002;16:75-83. (Pubitemid 34062184)
2. Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004;190:1670-6. (Pubitemid 39411018)
3. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006;43:42-6. (Pubitemid 44306486)
4. Velasco M, Castilla V, Sanz J, et al. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr 2009; 50:148-52.
5. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach - 2010 revision. Geneva: World Health Organization, 2010.
6. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011;365:1492-501.
7. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011; 365:1482-91.
8. Blanc F-X, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011;365:1471-81.
9. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010;362:697-706.
10. Marais S, Pepper DJ, Marais BJ, Török ME. HIV-associated tuberculous meningitis - diagnostic and therapeutic challenges. Tuberculosis (Edinb) 2010;90:367-74.
11. Török ME, Yen NT, Chau TT, et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV) - associated tuberculous meningitis. Clin Infect Dis 2011;52: 1374-83.